Skip to Main Content
Wyss Institute
Menu
Search Site
Who We Are
About
How We Work
How We Collaborate
Team
Careers
Contact
Our Work
Technologies
Impact Report
Business Insider
Publications
Collaborations
Brain Targeting Program
Collaborative Fund Alliance
Diagnostics Accelerator
i3 Center
Northpond Labs Alliance
Newsroom
News
Press Resources
Multimedia
Events
Give
Search
News search results
87 Results for ''
Awards
Kwasi Adu-Berchie named 2024 STAT Wunderkind
October 16, 2024
Translation News
Attivare licenses Wyss Institute’s immune-modulating biomaterial technology to advance immunotherapies
October 2, 2024
Community
Vinny Chandran Suja on Making Backpacks More Reliable and Predictable
August 20, 2024
Press Release
Wyss Institute promotes Natalie Artzi to its Core Faculty and appoints Di Feng as an Associate Faculty member
August 12, 2024
Community
Justin Scott on Engineering Proteins for Real-World Impact
June 26, 2024
Press Release
Boosting CAR-T cell therapies from under the skin
June 12, 2024
Press Release
Expanding a lymph node, boosting a vaccine
May 6, 2024
Press Release
Repairing patients’ dura more durably
March 20, 2024
Press Release
A new glue, potentially also for you
February 20, 2024
Research Spotlights
Announcing the 2024 “Faculty Focus” List
January 25, 2024
Research Spotlights
Changing the calculus of cancer treatment
January 25, 2024
Press Release
Biomaterial-delivered one-two punch boosts cancer immunotherapy
July 13, 2023
Press Release
Tuning T cell traits and functions with biomechanical materials
June 26, 2023
Press Release
Clearing a path for non-invasive muscle therapy for the elderly
March 22, 2023
Research Spotlights
Immunotherapy’s Next Act
March 15, 2023
Press Release
CAR-T cell cancer immunotherapy gets personal
February 10, 2023
Press Release
Enhanced cancer immunotherapies through cytokine-labeled T cells
January 10, 2023
Press Release
A soft, stimulating scaffold supports brain cell development
ex vivo
January 5, 2023
Awards
Elizabeth Carstens and Yang Claire Zeng selected as 3rd recipients of Harvard’s “Immuno-engineering to Improve Immunotherapy” (i3) Center award
December 14, 2022
Awards
14 Wyss Faculty named Highly Cited Researchers in 2022
November 16, 2022
Press Release
Wasting muscles built back better
November 14, 2022
Translation News
The Wyss Institute’s 2022-2023 Validation Projects
September 12, 2022
Research Spotlights
Activating STING could make brain tumors more susceptible to treatment
July 14, 2022
Press Release
Deconstructing the mechanics of bone marrow disease
July 11, 2022
Community
Nikolaos Dimitrakakis on Artificial Bone Marrow and Teamwork
June 17, 2022
Research Spotlights
New cancer vaccine delivers double punch to tumors
May 27, 2022
Translation News
Wyss Technologies Top Harvard’s 2022 President’s Innovation Challenge
May 9, 2022
Video/Animation
Giving old drugs new life…to save lives
February 17, 2022
Translation News
Alkem licenses technology from Harvard University, aiming to treat ischemic injury and vascular diseases
February 10, 2022
Press Release
Towards more effective tendon repair with a multi-functional biomaterial
January 3, 2022
Research Spotlights
“Immuno-engineering to Improve Immunotherapy” (i3) Center at Harvard University selects Dana-Farber cancer-immunologist Rizwan Romee as its 2021 grant recipient
December 13, 2021
Community
Sasha Stafford on Developing Drug Delivery Technology
October 29, 2021
Press Release
Massage doesn’t just make muscles feel better, it makes them heal faster and stronger
October 6, 2021
Press Release
Biomaterial vaccines ward off broad range of bacterial infections and septic shock
July 8, 2021
Press Release
Muscling up with nanoparticle-based anti-inflammatory therapy
June 24, 2021
Press Release
Electrodes that flow to fit the body
June 17, 2021
Research Spotlights
Harvard “Immuno-engineering to Improve Immunotherapy” (i3) Center at the Wyss Institute awards first grant to Dana-Farber cancer immunologist Eric Smith
January 21, 2021
Awards
A Year in Review: 2020
December 17, 2020
Video/Animation
Tough yet flexible treatment for babies in the womb
November 30, 2020
Community
Nada Langellotto on OMNIVAX: A Broadly Deployable Infection Vaccine Platform
November 12, 2020
Press Release
A viable vaccine for tough tumors
November 10, 2020
Community
The OMNIVAX team sets out to follow their dream
October 22, 2020
Research Spotlights
Putting a crown on OMNIVAX
August 17, 2020
Translation News
Wyss Institute’s tough gel technology licensed to Amend Surgical for oral surgery applications
July 21, 2020
Press Release
Better vaccines are in our blood
July 13, 2020
Research Spotlights
i3 Center: Biomaterials to Create T Cell Immunity
July 1, 2020
Press Release
Direct control of dendritic cells for tracking and immune modulation
May 18, 2020
Press Release
“Backpacks” boost immune cells’ ability to kill cancer
April 29, 2020
Awards
Harvard’s Wyss Institute announces cross-institutional “Immuno-engineering to Improve Immunotherapy (
i3
)” Center to advance cancer therapy
March 6, 2020
Press Release
A solid vaccine for liquid tumors
January 14, 2020
Community
The Next Decade in Science
January 13, 2020
Press Release
ELeCt-ing a better candidate for chemo delivery
November 13, 2019
Press Release
Another trick up the immune system’s sleeve: regrowing blood vessels
July 31, 2019
Press Release
Time heals all wounds, but this adhesive can help
July 24, 2019
Press Release
Helping transplanted stem cells stick around and do their jobs
July 15, 2019
Press Release
Hansjörg Wyss, Harvard M.B.A. ’65, Gives Unprecedented Third Major Gift to Harvard to Support the Wyss Institute’s Mission to Develop and Commercialize World-Changing Technologies
June 7, 2019
Community
Ben Freedman on Tough Gel Adhesives
May 22, 2019
Press Release
Blurring the Line Between Science, Art, and Design
May 10, 2019
Research Spotlights
Harnessing Nature to Beat Cancer
February 28, 2019
Research Spotlights
A bioengineered factory for T-cells
February 12, 2019
Press Release
A golden ticket to faster muscle recovery
October 1, 2018
Community
Hitchhiking his way to better drug delivery
July 16, 2018
Research Spotlights
Delivering insulin in a pill
June 25, 2018
Research Spotlights
Straight to the heart
June 11, 2018
Press Release
Personal cancer vaccines get their own boost
March 5, 2018
Press Release
Fast-tracking T cell therapies with immune-mimicking biomaterials
January 15, 2018
Press Release
Fresh blood for damaged tissues via alginate hydrogels
September 26, 2017
Community
The Wyss Institute Model
September 16, 2017
Video/Animation
Introducing ‘Immuno-Materials’ to immunotherapy
June 28, 2017
Press Release
Sticky when wet: strong adhesive for wound healing
July 27, 2017
Community
Kwasi Adu-Berchie on developing effective therapies against cancer
May 25, 2017
Community
Kyle Vining on improving treatments for diseases like cancer
May 11, 2017
Community
David Zhang on the other side of Immuno-Materials
May 3, 2017
Community
Aileen Li on the potential of Immuno-Materials
April 26, 2017
Community
Sandeep Koshy on the marriage of biomaterials with immunotherapy
April 20, 2017
Community
Seeing Is Believing: Therapeutic Cancer Vaccines
April 5, 2017
Press Release
Setting a trap for autoimmunity
April 10, 2017
Community
William Shih: Lego-Style Construction of Future Therapeutics From DNA
February 15, 2017
Press Release
David Mooney elected Fellow of the National Academy of Inventors
December 13, 2016
Press Release
Changing the fate of stem cells
November 30, 2015
Press Release
Inciting an immune attack on cancer cells
August 25, 2015
Press Release
Injectable 3D vaccines could fight cancer and infectious diseases
December 8, 2014
Press Release
Wyss Institute Core Faculty member elected to the Institute of Medicine of the National Academies
October 21, 2013
Translation News
Cross-disciplinary team from Harvard University and Dana-Farber Cancer Institute brings novel therapeutic cancer vaccine to human clinical trials
September 6, 2013
Community
A Fantastic Voyage through the Future of Nanomedicine
June 7, 2013
Press Release
Injectable sponge delivers drugs, cells, and structure
November 13, 2012
Press Release
First cancer vaccine to eliminate tumors in mice
November 25, 2009
Close search results
close menu
Who We Are
About
How We Work
How We Collaborate
Team
Careers
Contact
Our Work
Technologies
Impact Report
Business Insider
Publications
Collaborations
Brain Targeting Program
Collaborative Fund Alliance
Diagnostics Accelerator
i3 Center
Northpond Labs Alliance
Newsroom
News
Press Resources
Multimedia
Events
Give
Close menu
